ACR Appropriateness Criteria®: Local Excision in Early-Stage Rectal Cancer

William Blackstock, Suzanne M. Russo, W. Warren Suh, Bard C. Cosman, Joseph Herman, Mohammed Mohiuddin, Matthew M. Poggi, William F. Regine, Leonard Saltz, William Small, Jennifer Zook, Andre A. Konski

Research output: Contribution to journalArticle

Abstract

Low anterior resection or abdominoperineal resection is considered standard treatment for early rectal cancer. These procedures, however, carry a risk of morbidity and mortality that may not be warranted for early distal lesions, which may be treated with local excision. Emerging data has investigated the efficacy of local excision in patients with early stage rectal cancers. An expert panel designated by the American College of Radiology has reviewed supporting data, from a few prospective multi-institutional trials and a number of single-institution, retrospective reviews. The consensus recognizes the importance of accurate staging to identify patients who may be candidates for a local excision approach. Optimal candidates for local excision alone include small, low-lying T1 tumors, without adverse pathologic features. A number of procedures may be safely used including transanal, posterior trans-sphincteric, posterior proctotomy, transanal excision, or transanal microsurgery. It is important to note that none of these include lymph node evaluation, and depending on the risk of lymph node metastases, adjuvant radiation with or without chemotherapy may be warranted. Patients with positive margins or T3 lesions are at high risk of local recurrence and should be offered immediate APR or LAR. However, patients with high-risk T1 tumors, T2 tumors, or those who are not amenable to more radical surgery may benefit from adjuvant treatment. Data have also reported excellent local control rates for neoadjuvant radiation ± chemotherapy followed by local excision in higher risk patients, but it is not yet clear if this approach reduces recurrence rates over surgery alone.

Original languageEnglish (US)
Pages (from-to)193-200
Number of pages8
JournalCurrent Problems in Cancer
Volume34
Issue number3
DOIs
StatePublished - May 2010
Externally publishedYes

Fingerprint

Rectal Neoplasms
Lymph Nodes
Radiation
Recurrence
Drug Therapy
Neoplasms
Microsurgery
Radiology
Neoplasm Metastasis
Morbidity
Mortality
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Blackstock, W., Russo, S. M., Suh, W. W., Cosman, B. C., Herman, J., Mohiuddin, M., ... Konski, A. A. (2010). ACR Appropriateness Criteria®: Local Excision in Early-Stage Rectal Cancer. Current Problems in Cancer, 34(3), 193-200. https://doi.org/10.1016/j.currproblcancer.2010.04.005

ACR Appropriateness Criteria® : Local Excision in Early-Stage Rectal Cancer. / Blackstock, William; Russo, Suzanne M.; Suh, W. Warren; Cosman, Bard C.; Herman, Joseph; Mohiuddin, Mohammed; Poggi, Matthew M.; Regine, William F.; Saltz, Leonard; Small, William; Zook, Jennifer; Konski, Andre A.

In: Current Problems in Cancer, Vol. 34, No. 3, 05.2010, p. 193-200.

Research output: Contribution to journalArticle

Blackstock, W, Russo, SM, Suh, WW, Cosman, BC, Herman, J, Mohiuddin, M, Poggi, MM, Regine, WF, Saltz, L, Small, W, Zook, J & Konski, AA 2010, 'ACR Appropriateness Criteria®: Local Excision in Early-Stage Rectal Cancer', Current Problems in Cancer, vol. 34, no. 3, pp. 193-200. https://doi.org/10.1016/j.currproblcancer.2010.04.005
Blackstock, William ; Russo, Suzanne M. ; Suh, W. Warren ; Cosman, Bard C. ; Herman, Joseph ; Mohiuddin, Mohammed ; Poggi, Matthew M. ; Regine, William F. ; Saltz, Leonard ; Small, William ; Zook, Jennifer ; Konski, Andre A. / ACR Appropriateness Criteria® : Local Excision in Early-Stage Rectal Cancer. In: Current Problems in Cancer. 2010 ; Vol. 34, No. 3. pp. 193-200.
@article{b01d0306577a40a6b27b79bf8ac5ffac,
title = "ACR Appropriateness Criteria{\circledR}: Local Excision in Early-Stage Rectal Cancer",
abstract = "Low anterior resection or abdominoperineal resection is considered standard treatment for early rectal cancer. These procedures, however, carry a risk of morbidity and mortality that may not be warranted for early distal lesions, which may be treated with local excision. Emerging data has investigated the efficacy of local excision in patients with early stage rectal cancers. An expert panel designated by the American College of Radiology has reviewed supporting data, from a few prospective multi-institutional trials and a number of single-institution, retrospective reviews. The consensus recognizes the importance of accurate staging to identify patients who may be candidates for a local excision approach. Optimal candidates for local excision alone include small, low-lying T1 tumors, without adverse pathologic features. A number of procedures may be safely used including transanal, posterior trans-sphincteric, posterior proctotomy, transanal excision, or transanal microsurgery. It is important to note that none of these include lymph node evaluation, and depending on the risk of lymph node metastases, adjuvant radiation with or without chemotherapy may be warranted. Patients with positive margins or T3 lesions are at high risk of local recurrence and should be offered immediate APR or LAR. However, patients with high-risk T1 tumors, T2 tumors, or those who are not amenable to more radical surgery may benefit from adjuvant treatment. Data have also reported excellent local control rates for neoadjuvant radiation ± chemotherapy followed by local excision in higher risk patients, but it is not yet clear if this approach reduces recurrence rates over surgery alone.",
author = "William Blackstock and Russo, {Suzanne M.} and Suh, {W. Warren} and Cosman, {Bard C.} and Joseph Herman and Mohammed Mohiuddin and Poggi, {Matthew M.} and Regine, {William F.} and Leonard Saltz and William Small and Jennifer Zook and Konski, {Andre A.}",
year = "2010",
month = "5",
doi = "10.1016/j.currproblcancer.2010.04.005",
language = "English (US)",
volume = "34",
pages = "193--200",
journal = "Current Problems in Cancer",
issn = "0147-0272",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - ACR Appropriateness Criteria®

T2 - Local Excision in Early-Stage Rectal Cancer

AU - Blackstock, William

AU - Russo, Suzanne M.

AU - Suh, W. Warren

AU - Cosman, Bard C.

AU - Herman, Joseph

AU - Mohiuddin, Mohammed

AU - Poggi, Matthew M.

AU - Regine, William F.

AU - Saltz, Leonard

AU - Small, William

AU - Zook, Jennifer

AU - Konski, Andre A.

PY - 2010/5

Y1 - 2010/5

N2 - Low anterior resection or abdominoperineal resection is considered standard treatment for early rectal cancer. These procedures, however, carry a risk of morbidity and mortality that may not be warranted for early distal lesions, which may be treated with local excision. Emerging data has investigated the efficacy of local excision in patients with early stage rectal cancers. An expert panel designated by the American College of Radiology has reviewed supporting data, from a few prospective multi-institutional trials and a number of single-institution, retrospective reviews. The consensus recognizes the importance of accurate staging to identify patients who may be candidates for a local excision approach. Optimal candidates for local excision alone include small, low-lying T1 tumors, without adverse pathologic features. A number of procedures may be safely used including transanal, posterior trans-sphincteric, posterior proctotomy, transanal excision, or transanal microsurgery. It is important to note that none of these include lymph node evaluation, and depending on the risk of lymph node metastases, adjuvant radiation with or without chemotherapy may be warranted. Patients with positive margins or T3 lesions are at high risk of local recurrence and should be offered immediate APR or LAR. However, patients with high-risk T1 tumors, T2 tumors, or those who are not amenable to more radical surgery may benefit from adjuvant treatment. Data have also reported excellent local control rates for neoadjuvant radiation ± chemotherapy followed by local excision in higher risk patients, but it is not yet clear if this approach reduces recurrence rates over surgery alone.

AB - Low anterior resection or abdominoperineal resection is considered standard treatment for early rectal cancer. These procedures, however, carry a risk of morbidity and mortality that may not be warranted for early distal lesions, which may be treated with local excision. Emerging data has investigated the efficacy of local excision in patients with early stage rectal cancers. An expert panel designated by the American College of Radiology has reviewed supporting data, from a few prospective multi-institutional trials and a number of single-institution, retrospective reviews. The consensus recognizes the importance of accurate staging to identify patients who may be candidates for a local excision approach. Optimal candidates for local excision alone include small, low-lying T1 tumors, without adverse pathologic features. A number of procedures may be safely used including transanal, posterior trans-sphincteric, posterior proctotomy, transanal excision, or transanal microsurgery. It is important to note that none of these include lymph node evaluation, and depending on the risk of lymph node metastases, adjuvant radiation with or without chemotherapy may be warranted. Patients with positive margins or T3 lesions are at high risk of local recurrence and should be offered immediate APR or LAR. However, patients with high-risk T1 tumors, T2 tumors, or those who are not amenable to more radical surgery may benefit from adjuvant treatment. Data have also reported excellent local control rates for neoadjuvant radiation ± chemotherapy followed by local excision in higher risk patients, but it is not yet clear if this approach reduces recurrence rates over surgery alone.

UR - http://www.scopus.com/inward/record.url?scp=77953096666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953096666&partnerID=8YFLogxK

U2 - 10.1016/j.currproblcancer.2010.04.005

DO - 10.1016/j.currproblcancer.2010.04.005

M3 - Article

C2 - 20541057

AN - SCOPUS:77953096666

VL - 34

SP - 193

EP - 200

JO - Current Problems in Cancer

JF - Current Problems in Cancer

SN - 0147-0272

IS - 3

ER -